Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,666,400 | 3,871,600 | 3,830,200 | 4,018,800 | 5,922,500 |
| Marketable Securities | 785,400 | 955,400 | 1,567,100 | 1,665,500 | 974,600 |
| Receivables | 4,071,600 | 3,801,300 | 4,022,800 | 3,888,300 | 4,237,900 |
| Inventories | 3,445,800 | 2,740,000 | 2,928,800 | 2,643,800 | 2,299,800 |
| TOTAL | $12,573,600 | $11,928,300 | $13,104,700 | $13,038,700 | $14,248,200 |
| Non-Current Assets | |||||
| PPE Net | 8,053,500 | 7,963,900 | 7,975,500 | 7,760,200 | 7,760,300 |
| Investments And Advances | 3,646,600 | 4,568,900 | 7,624,900 | 6,313,900 | 4,029,800 |
| Intangibles | 5,034,800 | 2,884,200 | 2,814,300 | 0 | 0 |
| Other Non-Current Assets | 6,260,400 | 8,962,300 | 3,729,300 | 7,286,100 | 7,621,500 |
| TOTAL | $22,995,300 | $24,379,300 | $22,144,000 | $21,360,200 | $19,411,600 |
| Total Assets | $35,568,900 | $36,307,600 | $35,248,700 | $34,398,900 | $33,659,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,338,200 | 1,128,100 | 1,119,300 | 1,188,300 | 1,125,200 |
| Other current liabilities | 5,987,400 | 5,300,400 | 5,214,000 | 5,456,400 | 5,057,200 |
| TOTAL | $8,229,600 | $9,741,000 | $8,916,600 | $8,389,500 | $8,930,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,972,400 | 5,332,800 | 4,200,300 | 5,519,400 | 5,464,700 |
| Other Non-Current Liabilities | 4,776,600 | 5,845,700 | 4,491,099 | 5,716,100 | 5,728,600 |
| TOTAL | $12,749,000 | $11,178,500 | $8,691,399 | $11,235,500 | $11,193,300 |
| Total Liabilities | $20,978,600 | $20,919,500 | $17,608,000 | $19,625,000 | $20,124,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,106,093 | 1,111,104 | 1,119,713 | 1,134,412 | 1,160,407 |
| Common Shares | 691,300 | 694,600 | 698,500 | 716,600 | 724,100 |
| Retained earnings | 16,011,800 | 16,482,700 | 16,992,400 | 16,088,200 | 14,897,800 |
| Other shareholders' equity | -7,574,900 | -6,990,500 | -5,006,200 | -6,802,000 | -6,878,100 |
| TOTAL | $14,590,300 | $15,388,100 | $17,640,700 | $14,773,900 | $13,535,600 |
| Total Liabilities And Equity | $35,568,900 | $36,307,600 | $35,248,700 | $34,398,900 | $33,659,800 |